The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liquid biopsy in patients with metastatic pancreatic cancer using an optimized targeted sequencing approach: Data from the pancreatic cancer registry PanDaDETECT.
 
David Witte
No Relationships to Disclose
 
Frederick Czaja
No Relationships to Disclose
 
Celine Lugnier
No Relationships to Disclose
 
Magdalena Keller
Travel, Accommodations, Expenses - Roche
 
Stefanie Noepel-Duennebacke
No Relationships to Disclose
 
Ira Ekmekciu
No Relationships to Disclose
 
Oliver Overheu
Honoraria - Merck KGaA
 
Elena Schlageter
No Relationships to Disclose
 
C. Benedikt Westphalen
Honoraria - Bayer; GlaxoSmithKline; Ipsen; Merck Serono; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - BMS; Celgene; MSD; Rafael Pharmaceuticals; RedHill Biopharma; Roche; Shire
Research Funding - Boehringer Ingelheim (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Array BioPharma; Bayer; Celgene; Halozyme; RedHill Biopharma; Roche; SERVIER; Taiho Pharmaceutical
 
Anna-Lena Kraeft
No Relationships to Disclose
 
Doreen M. Gisder
No Relationships to Disclose
 
Waldemar Uhl
No Relationships to Disclose
 
Philipp Höhn
No Relationships to Disclose
 
Johanna Strotmann
No Relationships to Disclose
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Janssen-Cilag; Merck Serono; MSD; Pierre Fabre; Roche; Servier
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; MSD; Pierre Fabre; Roche
 
Andrea Tannapfel
Honoraria - Amgen; Falk Pharma; Medupdate; Merck; Pfizer
 
Jens Christmann
Stock and Other Ownership Interests - Novo Nordisk
Honoraria - AstraZeneca; Janssen-Cilag GmbH Germany; Merck; MSD Oncology; Qiagen
Consulting or Advisory Role - AstraZeneca; Sanofi Aventis GmbH